Shorter colds and milder symptoms among children who use ColdZyme
A user survey conducted by IPSOS shows positive results with use of ColdZyme® against common colds in children. According to the parents who were interviewed, a majority of the younger children (ages 4 to 12 years) experienced fewer days with common cold and milder symptoms. About one third responded that ColdZyme had protected their children from catching colds. Most of the parents would recommend ColdZyme to other families with children.In a survey conducted by IPSOS on behalf of Enzymatica in 2019, ColdZyme was evaluated by parents of 50 children aged 4 to 17 years. A majority of the